Topical timolol in open-angle glaucoma.

Area of Science:

• Ophthalmology
• Pharmacology

Background:

• Open-angle glaucoma management often requires advanced treatment strategies.
• Some patients experience inadequate intraocular pressure (IOP) control or adverse effects with conventional medications.

Purpose of the Study:

• To evaluate the efficacy and tolerability of timolol therapy in patients with open-angle glaucoma.
• To assess timolol's effectiveness in cases of medically uncontrolled or intolerant patients.

Main Methods:

• Thirty-seven patients with open-angle glaucoma were initiated on timolol therapy.
• Patients included those with inadequate IOP control or side effects from existing treatments.

Main Results:

• Timolol therapy significantly reduced intraocular pressure in the majority of patients.
• The medication was well-tolerated, with few reported side effects, though a slight decrease in pulse rate was observed in some.
• The pressure-lowering effect was additive to other medications and particularly beneficial for patients with previously uncontrolled IOP.

Conclusions:

• Timolol is an effective and well-tolerated treatment option for open-angle glaucoma.
• It provides a valuable therapeutic addition for patients with inadequately controlled intraocular pressure.
• The pressure-lowering effects of timolol appear to be sustained over time for most patients.